| Nancy Reynolds, OT | |
|
2525 S Michigan Ave, B-522, Chicago, IL 60616-2333 | |
| (312) 567-5550 | |
| (312) 567-2079 |
| Full Name | Nancy Reynolds |
|---|---|
| Gender | Female |
| Speciality | Physical Medicine & Rehabilitation |
| Location | 2525 S Michigan Ave, Chicago, Illinois |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205156890 | NPI | - | NPPES |
| 01621679 | Other | IL | BCBS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208100000X | Physical Medicine & Rehabilitation | 056001606 (Illinois) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Nancy Reynolds, OT 2525 S Michigan Ave, B-522, Chicago, IL 60616-2333 Ph: (312) 567-5550 | Nancy Reynolds, OT 2525 S Michigan Ave, B-522, Chicago, IL 60616-2333 Ph: (312) 567-5550 |
News Archive
Global land-use changes — including forest fragmentation, agricultural expansion and concentrated livestock production — are creating "hotspots" favorable for bats that carry coronaviruses and where conditions are ripe for the diseases to jump from bats to humans, finds a new analysis by researchers at the Politecnico di Milano, University of California, Berkeley and Massey University.
Call it "the sweet spot." The Greek Gods Yogurt is in the enviable target zones where yogurt sales are domestically growing most. In its most recent Nov. 2009 report, Mintel's industry data found the probiotic and protein-packed Greek Gods Yogurt brand situated in yogurt's most evident growth segments.
DaVita Clinical Research, a specialty contract research organization with services spanning a broad spectrum of drug and device development, announced today its Biospecimen Research Grant Program (BioReG), a grant program to award clinical-trial-quality biospecimens and annotated de-identified data to academic medical centers involved in kidney research.
Keryx Biopharmaceuticals, Inc. reported today that the Phase 3 "X-PECT" clinical trial evaluating perifosine (KRX-0401) + capecitabine (Xeloda) in patients with refractory advanced colorectal cancer did not meet the primary endpoint of improving overall survival versus capecitabine + placebo.
› Verified 5 days ago
Patrick Joseph Barrett, MD Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: 345 E Superior St, 16th Floor, Chicago, IL 60611 Phone: 312-238-2780 | |
Dr. Monica E Rho, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 355 E Erie St, Chicago, IL 60611 Phone: 312-238-1000 Fax: 312-238-7709 | |
Ms. Shivani Dua, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 1725 W Harrison St Ste 885, Chicago, IL 60612 Phone: 312-942-2384 | |
Kara Eder, DPT Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 333 E Benton Pl Ste 108, Chicago, IL 60601 Phone: 312-929-3646 | |
Dr. Sonika Randev, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 401 N Michigan Ave Ste 1200, Chicago, IL 60611 Phone: 312-635-0973 | |
Lauren E Splittgerber, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 355 E Erie St, Chicago, IL 60611 Phone: 312-238-1000 Fax: 312-238-7767 | |
Reza Zayn Tanveer, Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: 1620 W Harrison St, Chicago, IL 60612 Phone: 312-942-5000 |